The global circulating tumor cells market is positioned for substantial growth, with a projected value of USD 28.4 billion by 2030. This translates to a compelling CAGR (compound annual growth rate) of 13.4% during the forecast period of 2023-2030, according to a recent market analysis. The market was estimated at USD 10.4 billion in 2022. This press release explores the circulating...